» Articles » PMID: 24705807

Prevalence of Obstructive Sleep Apnea in Patients with Mucopolysaccharidosis Types I, II, and VI in a Reference Center

Overview
Journal Sleep Breath
Publisher Springer
Date 2014 Apr 8
PMID 24705807
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Mucopolysaccharidosis (MPS) encompasses a group of rare lysosomal storage disorders that are associated with the accumulation of glycosaminoglycans in organs and tissues. Respiratory disorders occur in all MPS types. In these patients, the prevalence of obstructive sleep apnea syndrome (OSAS), which may confer additional morbidity, remains overlooked, and the results of the few existing studies are controversial. The present study aimed to characterize the prevalence of OSAS in patients with MPS types I, II, and VI in a reference center.

Methods: Forty-five patients with MPS (I, n=17; II, n=16; and VI; n=12) in the Centro de Referência em Erros Inatos do Metabolismo, who underwent full-night polysomnography, were enrolled in a retrospective study. Demographic data and clinical history were collected from medical records of the first medical consultation.

Results: The prevalence of OSAS in patients with MPS was 69.8%. MPS type I patients seemed to be more susceptible to OSA-induced hypoxemia, as indicated by reduced mean SpO2 levels during both NREM and rapid eye movement sleep as well as during SpO2 nadir.

Conclusions: Patients with MPS displayed a high prevalence of OSAS, often with moderate to high severity. Together, our results reinforce the need for OSAS screening in all patients with MPS.

Citing Articles

Assessment of Positional Obstructive Sleep Apnea in Children Undergoing Adenotonsillectomy for Obstructive Sleep Apnea.

Ulualp S, Johnson R, Mitchell R Laryngoscope Investig Otolaryngol. 2025; 10(2):e70116.

PMID: 40046983 PMC: 11877339. DOI: 10.1002/lio2.70116.


Modeling Lysosomal Storage Disorders in an Innovative Way: Establishment and Characterization of Stem Cell Lines from Human Exfoliated Deciduous Teeth of Mucopolysaccharidosis Type II Patients.

Carvalho S, Santos J, Moreira L, Duarte A, Gaspar P, Rocha H Int J Mol Sci. 2024; 25(6).

PMID: 38542525 PMC: 10970756. DOI: 10.3390/ijms25063546.


Pediatric Sleep Respiratory Disorders: A Narrative Review of Epidemiology and Risk Factors.

Piotto M, Gambadauro A, Rocchi A, Lelii M, Madini B, Cerrato L Children (Basel). 2023; 10(6).

PMID: 37371187 PMC: 10296846. DOI: 10.3390/children10060955.


Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.

DAvanzo F, Rigon L, Zanetti A, Tomanin R Int J Mol Sci. 2020; 21(4).

PMID: 32070051 PMC: 7072947. DOI: 10.3390/ijms21041258.


Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases.

Faverio P, Stainer A, De Giacomi F, Gasperini S, Motta S, Canonico F Int J Mol Sci. 2019; 20(2).

PMID: 30650529 PMC: 6359090. DOI: 10.3390/ijms20020327.


References
1.
Wooten 3rd W, Muenzer J, Vaughn B, Muhlebach M . Relationship of sleep to pulmonary function in mucopolysaccharidosis II. J Pediatr. 2013; 162(6):1210-5. PMC: 3665636. DOI: 10.1016/j.jpeds.2012.11.039. View

2.
Muenzer J . The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr. 2004; 144(5 Suppl):S27-34. DOI: 10.1016/j.jpeds.2004.01.052. View

3.
Rao A, Tey B, Ramalingam G, Poh A . Obstructive sleep apnoea (OSA) patterns in bariatric surgical practice and response of OSA to weight loss after laparoscopic adjustable gastric banding (LAGB). Ann Acad Med Singap. 2009; 38(7):587-7. View

4.
Nashed A, Al-Saleh S, Gibbons J, MacLusky I, MacFarlane J, Riekstins A . Sleep-related breathing in children with mucopolysaccharidosis. J Inherit Metab Dis. 2009; 32(4):544-50. DOI: 10.1007/s10545-009-1170-4. View

5.
. Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. Am J Respir Crit Care Med. 1996; 153(2):866-78. DOI: 10.1164/ajrccm.153.2.8564147. View